MAOB and Parkinson disease: Although among anti‐PD medications, LD is most closely associated with the occurrence of motor complications in PD, other drugs such as DA agonists, MAO‐B inhibitors, and COMT inhibitors may also influence the development of motor complications to varying degrees.